BARCELONA and TORONTO, Nov. 15, 2017 /PRNewswire/ - Exact Imaging (www.exactimaging.com), the world's leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, is profiled extensively at the 6th Annual ESUI (EAU Section of Urological Imaging) 2017, which is being held on November 16, 2017 in Barcelona, Spain. The ExactVu technology will be discussed in two clinical talks, in four posters including two presentations and as a key technology in the Hands-On Training MRI/Ultrasound Fusion Workshop.
"As the ExactVu micro-ultrasound system is growing its installed base globally, it is becoming an essential tool for our customers to successfully visualize suspicious regions, to perform targeted biopsies and to thereby improve their detection of significant cancer," says Randy AuCoin, Exact Imaging's President and CEO. "We are pleased to have our micro-ultrasound platform profiled in so many separate instances at the ESUI, which represents some of the most prolific thinking in European imaging. Sharing evidence on the benefits of micro-ultrasound is an important indicator of the growing adoption of this technology into the urological community globally."
ExactVu micro-ultrasound and the PRI-MUS™ (prostate risk identification using micro-ultrasound) risk identification protocol are featured in the following talks: "High resolution ultrasound and fusion biopsy" by Dr. Lars Budäus (Martini Clinic, Hamburg, Germany) and "Feasibility Study for avoiding or postponing biopsy using improved imaging: Negative predictive value of micro-ultrasound for subjects with low PSAD"by Dr. Ander Astobieta Odriozola (Urología Clínica Bilbao, Urología Clínica, Bilbao, Spain). They are also featured in the four following clinical posters:
Ad Statistics
Times Displayed: 6368
Times Visited: 20 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Initial Results Comparing 29 MHz Micro-Ultrasound with Multi-Parametric MRI for Targeted Prostate Biopsy: Relative Sensitivity to Clinically Significant Prostate Cancer, Astobieta A. et al.
Feasibility Study for Avoiding or Postponing Biopsy using Improved Imaging: Negative Predictive Value of Micro-Ultrasound for Subjects with Low PSAD, Astobieta A et al.
Correlating Micro-Ultrasound Sonographic Features and PRI-MUS™ Ranking of
Prostate Cancer Lesions with Underlying Histo-pathology, J. Lin et al.
Comparison of Conventional TRUS, MRI and Micro-Ultrasound for Visualizing Prostate Cancer in an Active Surveillance Population: A Feasibility Study, G. Eure et al.
